Rho/ROCK/P13/Akt kinase inhibitors for the treatment of diseases associated with protozoan parasites

Details for Australian Patent Application No. 2007280619 (hide)

Owner Universite Pierre et Marie Curie-Paris VI

Inventors Taoufiq, Zacharie; Pino, Paco; Mazier, Dominique; Ciceron, Liliane

Agent Davies Collison Cave

Pub. Number AU-A-2007280619

PCT Pub. Number WO2008/015001

Priority 06291263.9 03.08.06 EP

Filing date 2 August 2007

Wipo publication date 7 February 2008

International Classifications

A61K 31/5513 (2006.01)

A61K 31/335 (2006.01) - having oxygen as the only ring hetero atom, e.g. fungichromin

A61K 31/35 (2006.01) - having six-membered rings with one oxygen as the only ring hetero atom

A61K 31/415 (2006.01) - 1,2-Diazoles

A61K 31/435 (2006.01) - having six-membered rings with one nitrogen as the only ring hetero atom

A61K 31/4409 (2006.01) - only substituted in position 4, e.g. isoniazid, iproniazid

A61K 31/47 (2006.01) - Quinolines

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

A61K 31/49 (2006.01) - Cinchonan derivatives, e.g. quinine

A61P 33/00 (2006.01) Antiparasitic agents

A61P 33/06 (2006.01) Antiparasitic agents

Event Publications

26 February 2009 PCT application entered the National Phase

  PCT publication WO2008/015001 Priority application(s): WO2008/015001

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007280625-Use of escin

2007280604-Derivatives of 4-trimethylammonium-3-aminobutyrate and 4-trimethylphosphonium-3-aminobutyrat e as CPT-inhibitors